Functional, morphological and molecular characterization of bladder dysfunction in streptozotocin-induced diabetic mice: Evidence of a role for L-type voltage-operated Ca 2+ channels

British Journal of Pharmacology

Volumn 163, Issue 6, 2011, Pages 1276-1288

  Leiria, L O S ^a   Monica F Z T ^a   Carvalho, F D G F ^a   Claudino, M A ^a   Franco Penteado, C F ^a   Schenka, A ^a   Grant, A D ^b   De Nucci, G ^a   Antunes, E ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

bladder dysfunction; detrusor smooth muscle; diabetes; L type Ca 2+ channels; Rho kinase

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; CALCIUM CHANNEL L TYPE; CALCIUM ION; CARBACHOL; MESSENGER RNA; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; NIFEDIPINE; POTASSIUM CHLORIDE; PURINERGIC P2X1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CAPACITY; BLADDER DYSFUNCTION; BLADDER PRESSURE; CALCIUM TRANSPORT; CONTROLLED STUDY; DETRUSOR MUSCLE; DIABETES MELLITUS; EXTRACELLULAR CALCIUM; FUNCTIONAL ASSESSMENT; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTION; STREPTOZOCIN DIABETES; TISSUE STRUCTURE; UROTHELIUM;

AMIDES; ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CALCIUM CHLORIDE; CARBACHOL; CHOLINERGIC AGONISTS; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL; NIFEDIPINE; PYRIDINES; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; RECEPTORS, PURINERGIC P2X1; RHO-ASSOCIATED KINASES; RNA, MESSENGER; URINARY BLADDER DISEASES;

EID: 79959745454     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01311.x     Document Type: Article

References (49)

1. Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD, et al,. (2006). Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol 148: 565-578. (Pubitemid 43993048)
2. Andersson KE, Arner A, (2004). Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev 84: 935-986. (Pubitemid 38823771)
3. Bayliss M, Wu C, Newgreen D, Mundy AR, Fry CH, (1999). A quantitative study of atropine-resistant contractile responses in human detrusor smooth muscle, from stable, unstable and obstructed bladders. J Urol 162: 1833-1839. (Pubitemid 29474738)
4. Brading AF, Williams JH, (1990). Contractile responses of smooth muscle strips from rat and guinea-pig urinary bladder to transmural stimulation: effects of atropine and a,-methylene ATP. Br J Pharmacol 99: 493-498. (Pubitemid 20069151)
5. Brown JS, Wessells H, Chancellor MB, Howards SS, Stamm WE, Stapleton AE, et al,. (2005). Urologic complications of diabetes. Diabetes Care 28: 177-185. (Pubitemid 40095802)
6. Calvert RC, Thompson C, Khan MA, Mikhailidis DP, Morgan RJ, Burnstock G, (2001). Alterations in cholinergic and purinergic signalling in a model of the obstructed bladder. J Urol 166: 1530-1533. (Pubitemid 32862233)
7. Chang S, Hypolite JA, DiSanto ME, Changolkar A, Wein AJ, Chacko S, (2006). Increased basal phosphorilation of detrusor smooth muscle myosin in alloxan-induced diabetic rabbit is mediated by upregulation of Rho-kinase β and CPI-17. Am J Physiol Renal Physiol 290: F650-F656. (Pubitemid 43724967)
8. Cheng JT, Yu BC, Tong YC, (2007). Changes of M3-muscarinic receptor protein and mRNA expressions in the bladder urothelium and muscle layer of streptozotocin-induced diabetic rats. Neurosci Lett 423: 1-5.
9. Chitaley K, Weber D, Webb RC, (2001). RhoA/Rho-kinase, vascular changes, and hypertension. Curr Hypertens Rep 3: 139-144.
10. Christ GJ, Andersson KE, (2007). Rho-kinase and effects of rho-kinase inhibition on the lower urinary tract. Neurourol Urodyn 26: 948-954. (Pubitemid 47548232)
11. Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I, (2008). The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int 101: 1388-1395. (Pubitemid 351623990)
12. Daneshgari F, Huang X, Liu G, Bena J, Saffore L, Powell CT, (2006). Temporal differences in bladder dysfunction caused by diabetes, diuresis, and treated diabetes in mice. Am J Physiol Regul Integr Comp Physiol 290: R1728-R1735. (Pubitemid 43830841)
13. Eika B, Levin RM, Longhurst PA, (1994). Comparison of urinary bladder function in rats with hereditary diabetes insipidus, streptozotocin-induced diabetes mellitus, and nondiabetic osmotic diuresis. J Urol 151: 496-502. (Pubitemid 24047042)
14. Faerman I, Glocer L, Celener D, Jadzinsky M, Fox D, Maler M, et al,. (1973). Autonomic nervous system and diabetes. Histological and histochemical study of the autonomic nerve fibers of the urinary bladder in diabetic patients. Diabetes 22: 225-237.
15. Hirayama A, Fujimoto K, Matsumoto Y, Ozono S, Hirao Y, (2003). Positive response to ice water test associated with high-grade bladder outlet obstruction in patients with benign prostatic hyperplasia. Urology 62: 909-913. (Pubitemid 37421241)
16. Igawa Y, Zhang X, Nishizawa O, Umeda M, Iwata A, Taketo MM, et al,. (2004). Cystometric findings in mice lacking muscarinic M2 or M3 receptors. J Urol 172: 2460-2464. (Pubitemid 39507553)
17. Irwin DE, Milsom I, Reilly K, Hunskaar S, Kopp Z, Herschorn S, et al,. (2008). Overactive bladder is associated with erectile dysfunction and reduced sexual quality of life in men. J Sex Med 5: 2904-2910.
18. Kaplan SA, Te AE, Blaivas JG, (1995). Urodynamic findings in patients with diabetic cystopathy. J Urol 153: 342-344.
19. Koshimizu TA, Van Goor F, Tomić M, Wong AO, Tanoue A, Tsujimoto G, et al,. (2000). Characterization of calcium signaling by purinergic receptor-channels expressed in excitable cells. Mol Pharmacol 58: 936-945.
20. 2+ release and entry during contraction elicited by norepinephrine in rat resistance arteries. Am J Physiol 276: H300-H308. (Pubitemid 29065649)
21. Lee DL, Webb RC, Jin L, (2004). Hypertension and RhoA/Rho-kinase signaling in the vasculature: highlights from the recent literature. Hypertension 44: 796-799. (Pubitemid 39577399)
22. Liu G, Daneshgari F, (2005). Alterations in neurogenically mediated contractile responses of urinary bladder in rats with diabetes. Am J Physiol Renal Physiol 288: F1220-F1226. (Pubitemid 40677092)
23. Longhurst PA, Levendusky MC, Bezuijen MWF, (2004). Diabetes mellitus increases the rate of development of decompensation in rats with outlet obstruction. J Urol 171: 933-937. (Pubitemid 38090537)
24. Matsui M, Motomura D, Karasawa H, Fujikawa T, Jiang J, Komiya Y, et al,. (2000). Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. Proc Natl Acad Sci USA 97: 9579-9584. (Pubitemid 30650818)
25. Melman A, Zotova E, Kim M, Arezzo J, Davies K, DiSanto M, et al,. (2009). Longitudinal studies of time-dependent changes in both bladder and erectile function after streptozotocin-induced diabetes in Fischer 344 male rats. BJU Int 104: 1292-1300.
26. Nobe K, Yamazaki T, Tsumita N, Hashimoto T, Honda K, (2009). Glucose-dependent enhancement of diabetic bladder contraction is associated with a Rho kinase-regulated protein kinase C pathway. J Pharmacol Exp Ther 28: 940-950.
27. O'Reilly BA, Kosaka AH, Chang TK, Ford AP, Popert R, McMahon SB, (2001). A quantitative analysis of purinoceptor expression in the bladders of patients with symptomatic outlet obstruction. BJU Int 87: 617-622. (Pubitemid 34293751)
28. Pak KJ, Ostrom RS, Matsui M, Ehlert FJ, (2010). Impaired M3 and enhanced M2 muscarinic receptor contractile function in a streptozotocin model of mouse diabetic urinary bladder. Naunyn Schmiedebergs Arch Pharmacol 381: 441-454.
29. Palea S, Artibani W, Ostardo E, Trist DG, Pietra C, (1993). Evidence for purinergic neurotransmission in human urinary bladder affected by interstitial cystitis. J Urol 150: 2007-2012. (Pubitemid 24350854)
30. Poladia DP, Bauer JA, (2004). Oxidant driven signaling pathways during diabetes: role of Rac1 and modulation of protein kinase activity in mouse urinary bladder. Biochimie 86: 543-551. (Pubitemid 39237652)
31. Poladia DP, Bauer JA, (2005). Functional, structural, and neuronal alterations in urinary bladder during diabetes: investigations of a mouse model. Pharmacology 74: 84-94. (Pubitemid 40827590)
32. Rapp DE, Lyon MB, Bales GT, Cook SP, (2005). A role for the P2X receptor in urinary tract physiology and in the pathophysiology of urinary dysfunction. Eur Urol 48: 303-308. (Pubitemid 40957109)
33. 2+ release in the muscarinic-mediated contraction of mammalian urinary bladder smooth muscle. BJU Int 98: 868-875. (Pubitemid 44368042)
34. Saito M, Okada S, Kazuyama E, Satoh I, Kinoshita Y, Satoh K, (2008). Pharmacological properties, functional alterations and gene expression of muscarinic receptors in young and old type 2 Goto-Kakizaki diabetic rat bladders. J Urol 180: 2701-2705.
35. Stein R, Hutcheson JC, Gong C, Canning DA, Carr MC, Zderic SA, (2001). The decompensated detrusor IV: experimental bladder outlet obstruction and its functional correlation to the expression of the ryanodine and voltage operated calcium channels. J Urol 165: 2284-2288. (Pubitemid 32423912)
36. Su X, Changolkar A, Chacko S, Moreland RS, (2004). Diabetes decreases rabbit bladder smooth muscle contraction while increasing levels of myosin light chain phosphorylation. Am J Physiol Renal Physiol 287: F690-F699. (Pubitemid 39280503)
37. Suadicani SO, Urban-Maldonado M, Tar MT, Melman A, Spray DC, (2009). Effects of ageing and streptozotocin-induced diabetes on connexin43 and P2 purinoceptor expression in the rat corpora cavernosa and urinary bladder. BJU Int 103: 1686-1693.
38. Suzuki Y, Inoue T, Ra C, (2010). L-type Ca2+ channels: a new player in the regulation of Ca2+ signaling, cell activation and cell survival in immune cells. Mol Immunol 47: 640-648.
39. Tammela TL, Briscoe JA, Levin RM, Longhurst PA, (1994). Factors underlying the increased sensitivity to field stimulation of urinary bladder strips from streptozotocin-induced diabetic rats. Br J Pharmacol 113: 195-203. (Pubitemid 24271737)
40. Tammela TLJ, Leggett RE, Levin RM, Longhurst PA, (1995). Temporal changes in micturition and bladder contractility after sucrose dieresis and streptozotocin-induced diabetes mellitus in rats. J Urol 153: 2014-2021.
41. Torimoto K, Fraser MO, Hirao Y, de Groat WC, Chancellor MB, Yoshimura N, (2004). Urethral dysfunction in diabetic rats. J Urol 171: 1959-1964. (Pubitemid 38501053)
42. Turner WH, Brading AF, (1999). Smooth muscle of the bladder in the normal and the diseased state: pathophysiology, diagnosis and treatment. Pharmacol Ther 75: 77-110.
43. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, et al,. (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH 0034.
44. Vinik AI, Maser RE, Mitchell BD, Freeman R, (2003). Diabetic autonomic neuropathy. Diabetes Care 26: 1553-1579. (Pubitemid 36934465)
45. Waring JV, Wendt IR, (2000). Effects of streptozotocin-induced diabetes mellitus on intracellular calcium and contraction of longitudinal smooth muscle from rat urinary bladder. J Urol 163: 323-330.
46. Wegener JW, Schulla V, Lee TS, Koller A, Feil S, Feil R, et al,. (2004). An essential role of Cav1.2 L-type calcium channel for urinary bladder function. FASEB J 18: 1159-1161. (Pubitemid 39561556)
47. Yoshimura N, (1999). Bladder afferent pathway and spinal cord injury: possible mechanisms inducing hyperreflexia of the urinary bladder. Prog Neurobiol 57: 583-606. (Pubitemid 29148416)
48. Yoshimura N, Chancellor MB, Andersson KE, Christ GJ, (2005). Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int 95: 733-738. (Pubitemid 40547197)
49. Yoshimura N, Kaiho Y, Miyazato M, Yunoki T, Tai C, Chancellor MB, et al,. (2008). Therapeutic receptor targets for lower urinary tract dysfunction. Naunyn Schmiedebergs Arch Pharmacol 377: 437-448.